Literature DB >> 12898238

Acquired angioedema and Helicobacter pylori infection in a child.

Jana Varvarovska1, Josef Sykora, Frantisek Stozicky, Ivan Chytra.   

Abstract

UNLABELLED: We describe a 10-year-old boy with acquired Helicobacter pylori infection and simultaneous angioedema which is a rare but life-threatening condition. Our patient was hospitalised with generalised angioedema and severe circulatory shock due to extreme loss of fluids and proteins into interstitial tissues (weight gain 10 kg within 2 days, extreme haemoconcentration--haemoglobin 206 g/l, haematocrit 0.570, leucocytosis 18,300 /microl, high lactate 13.8 mmol/l) and simultaneous failure of the complement system (C3 <0.16 g/l, C4 <0.13 g/l, CH50 45 U/ml, i.e. 50% of normal value, C1 inhibitor 0.21 g/l at the lower limit). All possible known causes of angioedema were excluded (infection, allergy, auto-immune disease, NSAIDs, lymphoproliferative disease) except for the simultaneous H. pylori infection which was proven serologically and histologically. Eradication therapy led to a complete remission of the H. pylori infection. An absence of angioedema and the restoration of the complement system was later observed. To the best of our knowledge, no similar case report of a child has yet been published.
CONCLUSION: Helicobacter pylori infection should be considered in the development of angioedema in childhood.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12898238     DOI: 10.1007/s00431-003-1250-7

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  7 in total

1.  Eradication of Helicobacter pylori and improvement of hereditary angioneurotic oedema.

Authors:  H Farkas; G Füst; B Fekete; I Karádi; L Varga
Journal:  Lancet       Date:  2001-11-17       Impact factor: 79.321

2.  Angioedema due to acquired C1-esterase inhibitor deficiency in a patient with Helicobacter pylori infection.

Authors:  H Farkas; L Gyeney; P Majthényi; G Füst; L Varga
Journal:  Z Gastroenterol       Date:  1999-06       Impact factor: 2.000

Review 3.  Extraintestinal pathology associated with Helicobacter infection.

Authors:  A Gasbarrini; F Franceschi; G Gasbarrini; P Pola
Journal:  Eur J Gastroenterol Hepatol       Date:  1997-03       Impact factor: 2.566

Review 4.  Helicobacter pylori: beyond peptic ulcer disease.

Authors:  R M Wisniewski; D A Peura
Journal:  Gastroenterologist       Date:  1997-12

5.  Helicobacter pylori infection affects eosinophilic cationic protein in the gastric juice of patients with idiopathic chronic urticaria.

Authors:  V Ojetti; A Armuzzi; A De Luca; E Nucera; F Franceschi; M Candelli; G F Zannoni; S Danese; S Di Caro; M Vastola; D Schiavino; G Gasbarrini; G Patriarca; P Pola; A Gasbarrini
Journal:  Int Arch Allergy Immunol       Date:  2001-05       Impact factor: 2.749

6.  Prevalence of Helicobacter pylori-associated gastritis in chronic urticaria.

Authors:  B Wedi; S Wagner; T Werfel; M P Manns; A Kapp
Journal:  Int Arch Allergy Immunol       Date:  1998-08       Impact factor: 2.749

7.  Hereditary and acquired C1-inhibitor deficiency: biological and clinical characteristics in 235 patients.

Authors:  A Agostoni; M Cicardi
Journal:  Medicine (Baltimore)       Date:  1992-07       Impact factor: 1.889

  7 in total
  4 in total

Review 1.  [Infections and chronic spontaneous urticaria. A review].

Authors:  B Wedi; U Raap; D Wieczorek; A Kapp
Journal:  Hautarzt       Date:  2010-09       Impact factor: 0.751

2.  Acquired angioedema.

Authors:  Marco Cicardi; Andrea Zanichelli
Journal:  Allergy Asthma Clin Immunol       Date:  2010-07-28       Impact factor: 3.406

3.  Case Title: 45 year-old male with recurrent angioedema: WAO international case-based discussions.

Authors:  Jennifer W Leiding; Douglas Beakes; Stephen C Dreskin; Anete Grumach; Michihiro Hide; Avner Reshef; Massimo Triggiani; Michael A Kaliner
Journal:  World Allergy Organ J       Date:  2014-01-22       Impact factor: 4.084

4.  Urticaria and infections.

Authors:  Bettina Wedi; Ulrike Raap; Dorothea Wieczorek; Alexander Kapp
Journal:  Allergy Asthma Clin Immunol       Date:  2009-12-01       Impact factor: 3.406

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.